Evidence map›Paper›PMID 39103402›Full record

ArticleScientific reports2024

Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions.

Hanaa Mohammed, Mustafa M Karhib, Karrar Sabah Jaafar Al-Fahad, Atef Mohamed Atef, Areej Eskandrani, Amira Abd-Elfattah Darwish, Ahmed Abdallah Sary, Bassma H Elwakil, Basant A Bakr, Ahmed M Eldrieny

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hanaa MohammedHuman Anatomy and Embryology Department, Faculty of Medicine, Sohag University, Sohag, Egypt.
Mustafa M KarhibDepartment of Medical Laboratory Techniques, College of Health and Medical Technologies, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq.
Karrar Sabah Jaafar Al-FahadBabylon Education Directorate, Ministry of Education, Hillah, Iraq.
Atef Mohamed AtefFaculty of Medical Applied Science, Irbid National University, Irbid, Jordan.
Areej EskandraniCollege of Science, Taibah University, 30002, Madinah, Kingdom of Saudi Arabia.
Amira Abd-Elfattah DarwishFaculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt.
Ahmed Abdallah SaryFaculty of Physical Therapy, Pharos University in Alexandria, Alexandria, 21526, Egypt.
Bassma H ElwakilFaculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt. Bassma.hassan@pua.edu.eg.
Basant A BakrFaculty of Science, Alexandria University, Alexandria, 21321, Egypt.
Ahmed M EldrienyFaculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, 21526, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is among the highest morbidity and mortality rates in women around the world. In the present investigation we aimed to synthesis novel nanosystem combining two naturally important anticancer agents with different mechanism of action namely Moringa oleifera and caffeine. Firstly, chemical analysis of Moringa oleifera extract and caffeine was done by gas chromatography-mass spectroscopy (GC-MS) in order to assess the main chemical compounds present and correlate between them and the possible anticancer effect. The novel nanosystem was characterized through dynamic light scattering techniques which revealed the stability and homogeneity of the prepared M. oleifera leaves extract/Caffeine loaded chitosan nanoparticles, while FTIR and transmission electron microscope (TEM) proved the shape and the successful incorporation of M. oleifera leaves extract/Caffeine onto the nanochitosan carrier. Our initial step was to assess the anticancer effect in vitro in cancer cell line MCF-7 which proved the significant enhanced effect of M. oleifera leaves extract/Caffeine nanosystem compared to M. oleifera leaves extract or caffeine loaded nanoparticles. Further studies were conducted in vivo namely tumor biomarkers, tumor volume, bioluminescence imaging, molecular and histopathological investigations. The present study proved the potent anticancer effect of the synthesized M. oleifera leaves extract/Caffeine loaded chitosan nanoparticles. Mo/Caf/CsNPs exhibited a large number of apoptotic cells within the tumor mass while the adipose tissue regeneration was higher compared to the positive control. The prepared nanoparticles downregulated the expression of Her2, BRCA1 and BRCA2 while mTOR expression was upregulated. The aforementioned data demonstrated the successful synergistic impact of Moringa and caffeine in decreasing the carcinoma grade.

Indexed as

BRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCaffeineChitosanErb-b2 Receptor Tyrosine KinasesNanoparticlesPlant ExtractsPlant LeavesAnimalsFemaleGene Expression Regulation, NeoplasticHumansMCF-7 CellsMiceMoringa oleiferaBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanCaffeineChitosanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesPlant ExtractsBRCA1BRCA2Breast cancerChitosanHer2MCF-7mTORNano carrierNatural anticancer agents

Identifiers

PMID39103402
PMCPMC11300450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.